SSRP1 and central nervous system cancer: Additionally, inhibiting SSRP1 has been shown to suppress the migration and invasion of glioma cells.37 These observations suggest that SSRP1 may contribute to the aggressive behavior of GBM cells, making it a potential therapeutic target for combating the disease.